Dowling Chemical ($20bn sales) is evaluating a merger with Chem-X ($10bn sales), a direct competitor in the plastics market. The case requires analyzing whether $4.15bn in synergies (cost savings and pricing power) justify $4bn in merger costs, identifying specific synergy sources, and assessing execution risks including regulatory, cultural, and operational challenges.
Key Insights:
- Understand how to calculate synergy value using peer EV/EBITDA multiples and EBITDA margins rather than just absolute dollar amounts
- Distinguish between fixed cost synergies (IT, headcount, facilities) and variable cost synergies (purchasing power, manufacturing, distribution)
- Recognize that in consolidated, commodity-based industries, regulatory and antitrust concerns can be deal-breakers despite attractive financial economics
- Revenue synergies from pricing power and cross-selling can be just as valuable as cost synergies in consolidation scenarios
- Integration risks (culture, systems, management structure) require equal attention to financial analysis for deal success